P Charbonneau

708 total citations
32 papers, 511 citations indexed

About

P Charbonneau is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, P Charbonneau has authored 32 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Infectious Diseases. Recurrent topics in P Charbonneau's work include Respiratory viral infections research (5 papers), Antibiotic Use and Resistance (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). P Charbonneau is often cited by papers focused on Respiratory viral infections research (5 papers), Antibiotic Use and Resistance (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). P Charbonneau collaborates with scholars based in France, United States and United Kingdom. P Charbonneau's co-authors include Damien du Cheyron, Cédric Daubin, Michel Ramakers, M. Crouzel, C. Prenant, C. Crouzel, A. Syrota, P. Thibon, Jean‐Jacques Parienti and Roland Leclercq and has published in prestigious journals such as Circulation, Clinical Infectious Diseases and American Heart Journal.

In The Last Decade

P Charbonneau

28 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Charbonneau France 10 135 125 90 85 84 32 511
J Broomhall United Kingdom 7 78 0.6× 68 0.5× 21 0.2× 40 0.5× 59 0.7× 11 747
Charikleia S. Vrettou Greece 11 101 0.7× 74 0.6× 32 0.4× 34 0.4× 47 0.6× 49 432
Noah Moss United States 12 77 0.6× 302 2.4× 17 0.2× 181 2.1× 146 1.7× 43 753
Marko Folić Serbia 13 107 0.8× 50 0.4× 46 0.5× 14 0.2× 50 0.6× 60 438
Zsolt Iványi Hungary 11 125 0.9× 32 0.3× 33 0.4× 61 0.7× 150 1.8× 27 545
Yukihisa Miyazawa Japan 12 107 0.8× 57 0.5× 56 0.6× 33 0.4× 63 0.8× 37 488
Aileen McCabe Ireland 8 230 1.7× 226 1.8× 9 0.1× 79 0.9× 23 0.3× 19 576
Rishi Chanderraj United States 13 502 3.7× 145 1.2× 22 0.2× 76 0.9× 203 2.4× 22 916
Kaoru Okazaki Japan 12 134 1.0× 50 0.4× 67 0.7× 19 0.2× 40 0.5× 53 488
Angelo Gratarola Italy 10 92 0.7× 155 1.2× 33 0.4× 51 0.6× 18 0.2× 20 378

Countries citing papers authored by P Charbonneau

Since Specialization
Citations

This map shows the geographic impact of P Charbonneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Charbonneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Charbonneau more than expected).

Fields of papers citing papers by P Charbonneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Charbonneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Charbonneau. The network helps show where P Charbonneau may publish in the future.

Co-authorship network of co-authors of P Charbonneau

This figure shows the co-authorship network connecting the top 25 collaborators of P Charbonneau. A scholar is included among the top collaborators of P Charbonneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Charbonneau. P Charbonneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blanchart, Katrien, et al.. (2014). Fatal pulmonary lymphomatoid granulomatosis in a patient taking methotrexate for rheumatoid arthritis.. PubMed. 80(1). 119–20. 6 indexed citations
2.
Fourrier, F., P Charbonneau, F. Leclerc, et al.. (2012). 300 recommendations and guidelines on structural and organizational requirements for intensive care units. Réanimation. 8 indexed citations
3.
Parienti, Jean‐Jacques, Vincent Cattoir, P. Thibon, et al.. (2011). Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis. Journal of Hospital Infection. 78(2). 118–122. 38 indexed citations
4.
Cheyron, Damien du, Nicolas Terzi, & P Charbonneau. (2008). Les nouveaux marqueurs biologiques de l’insuffisance rénale aiguë. Réanimation. 17(8). 775–782. 6 indexed citations
5.
Freymuth∘, F., Astrid Vabret, Julia Dina, et al.. (2007). Techniques actuelles de diagnostic des infections virales respiratoires en réanimation. Réanimation. 16(3). 200–209. 2 indexed citations
6.
Cheyron, Damien du, Bruno Bouchet, & P Charbonneau. (2007). Insuffisance rénale aiguë chez les patients cirrhotiques en réanimation : incidence et pronostic. Réanimation. 16(7-8). 595–604.
7.
Charbonneau, P, Jean‐Jacques Parienti, P. Thibon, et al.. (2006). Fluoroquinolone Use and Methicillin-Resistant Staphylococcus aureus Isolation Rates in Hospitalized Patients: A Quasi Experimental Study. Clinical Infectious Diseases. 42(6). 778–784. 119 indexed citations
8.
Freymuth∘, F., Astrid Vabret, S. Gouarin, et al.. (2004). Épidémiologie et diagnostic des infections à virus respiratoire syncytial de l’adulte. Revue des Maladies Respiratoires. 21(1). 35–42. 16 indexed citations
9.
Cheyron, Damien du, Anne Lesage, Cédric Daubin, Michel Ramakers, & P Charbonneau. (2003). Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure. Intensive Care Medicine. 29(10). 1703–1709. 59 indexed citations
10.
Charbonneau, P. (1998). [Empirical antibiotic therapy for nosocomial pneumonia acquired in assisted ventilation].. PubMed. 27(26). 1362–4. 1 indexed citations
11.
Charbonneau, P. (1994). Review of piperacillin/tazobactam in the treatment of bacteremic infections and summary of clinical efficacy. Intensive Care Medicine. 20(S3). S43–S48. 8 indexed citations
12.
Charbonneau, P, Ian Harding, Jean–Jacques Garaud, et al.. (1994). Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for Gram-positive infections in intensive care patients. Intensive Care Medicine. 20(S4). S35–S42. 26 indexed citations
13.
Petitjean, J., H. Kopecká, F. Freymuth∘, et al.. (1992). Detection of enteroviruses in endomyocardial biopsy by molecular approach. Journal of Medical Virology. 37(1). 76–82. 39 indexed citations
14.
Fukuda, Hiroyuki, A. Syrota, P Charbonneau, et al.. (1986). Use of 11C-triphenylmethylphosphonium for the evaluation of membrane potential in the heart by positron-emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 11(12). 478–83. 24 indexed citations
15.
Grollier, Gilles, et al.. (1986). Myocardial dissection in right ventricular infarction: Two-dimensional echocardiographic recognition and pathologic study. American Heart Journal. 111(2). 422–425. 8 indexed citations
16.
Charbonneau, P, et al.. (1985). [Torsades de pointes in alcoholics].. PubMed. 14(11). 643–643. 1 indexed citations
17.
Derlon, J M, et al.. (1983). [Edematous cerebellar infarction in the young subject].. PubMed. 29(6). 423–8. 1 indexed citations
18.
Freymuth∘, F., Charlotte E. Boucher, M Larchet, et al.. (1983). [Direct immunofluorescence diagnosis in the epidemiology of acute viral respiratory infections in young children].. PubMed. 30(6). 433–7. 4 indexed citations
19.
Charbonneau, P, et al.. (1982). Respiratory and non-respiratory causes of death in the rat exposed to normobaric oxygen.. PubMed. 18(4). 633–42. 9 indexed citations
20.
Freymuth∘, F., et al.. (1981). Bronchiolites du nourrisson à virus respiratoire syncytial: Intérêt et limites des techniques d'immunofluorescence pour le diagnostic rapide, direct et indirect. Annales de l Institut Pasteur Virologie. 132(3). 389–393. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026